About Us


Delphine Collin, Ph.D.

Vice President, Biomolecular Sciences

Delphine Collin joins Cedilla from HarkerBIO, where she served as their chief innovation officer. Prior to HarkerBIO, she served as senior principal scientist at Boehringer Ingelheim (BI) and led a biophysics group focused on lead identification and optimization in the small molecule drug discovery group. While at BI, Delphine also started her own consulting firm, Delphine Collin Consulting, LLC., where she supported companies with specialized biophysical approaches to drug discovery. Prior to BI, Delphine was a research fellow at Merck & Co. Delphine holds a Ph.D. in biophysical chemistry and doctorate in pharmaceutical sciences from the University of Paris XI, France.